FDA’s Quality Management Maturity Program:
Why should CDMOs adhere to the new CDER’s Rating System?

Bispecific antibodies unleashed

Leveraging efficiency from cell line development to clinical manufacturing of monoclonal antibodies

Leveraging the immunological diversity of the PentaMice® platform for COVID-19 antibody discovery

Antibody-based drug discovery at the speed of light

Comprehensive mRNA Solutions

Casual Nexus – Episode Six: Biocatalysis, Biosynthesis and Fermentation – The Evolution of Chemistry via Biology

Casual Nexus – Episode Five: Saving Time in Hit-to-Lead Investigations

Hit-to-Lead Optimization Strategy in Drug Discovery

Drug Polymorphism: A Key Consideration for API Development

Key Considerations for End-to-End Primary Packaging Solutions for Pharmaceuticals & Devices

Solid Form Selection in Drug Development